Abstract

Chinese sacbrood virus (CSBV) infects Apis cerana larvae, resulting in the inability of the larvae to pupate and their consequent death, which may pose a serious threat to entire colonies. As there is no effective medical treatment for CSBV infections, further studies are necessary. In this study, an effective treatment for CSBV is described, based on a specific immunoglobulin Y (IgY) from egg yolk against CSBV. The inactivated vaccine was produced by ultracentrifugation and formalin treatment, using CSBV purified from a natural outbreak. The specific IgY was produced by immunization of white leghorn hens with the vaccine. An enzyme-linked immunosorbent assay using purified CSBV as the coating antigen revealed that the anti-CSBV IgY titer began increasing in the egg yolk on the 14th day post-immunization, reaching a peak on day 42, and anti-CSBV IgY remained at a high level until day 91. IgY isolated from the combinations of egg yolk collected between days 42–91 was purified by PEG and ammonium sulfate precipitation. In three repeated protection experiments using A. cerana larvae inoculated with CSBV, the survival rate of larvae was more than 80%, and the titer of anti-CSBV IgY was more than 25 and 24 when the larvae were fed IgY 24 h after and before inoculation with CSBV, respectively. Therefore, 400 colonies infected with CSBV were treated by feeding sugar containing IgY solutions with an antibody titer of 25, and the cure rate was 95–100%. Three hundred susceptible colonies were protected by feeding the larvae with sugar containing IgY solutions with an antibody titer of 24, and the protection rate was 97%. The results clearly suggest that a specific IgY was obtained from hens immunized with an inactivated-CSBV vaccine; this may be a novel method for controlling CSBV infection.

Highlights

  • A large number of Apis cerana and Apis mellifera are raised in China, which provide a wealth of nutrient-rich beehive products and pollinate a wide variety of crops and flowers

  • Chinese sacbrood virus (CSBV) was identified by reverse transcription (RT) polymerase chain reaction (PCR) methodology to exclude black queen cell virus (BQCV), acute bee paralysis virus (ABPV), chronic bee paralysis virus (CBPV), deformed wing virus (DWV), Kashmir bee virus (KBV), and Israeli acute paralysis virus (IAPV), following the method of Hu et al (2016)

  • The enzyme-linked immunosorbent assay (ELISA) assay revealed that the anti-CSBV antibody titer began to rise in the sera of inoculated white leghorn hens 14 days after the first immunization

Read more

Summary

Introduction

A large number of Apis cerana and Apis mellifera are raised in China, which provide a wealth of nutrient-rich beehive products and pollinate a wide variety of crops and flowers. Honeybees often die or escape, and it is possible for the entire colony to collapse because of infection with pathogens such as viruses, bacteria, fungi, parasites, and protozoa (Schmid-Hempel and Schmid-Hempel, 1998; Liu et al, 2010). Application of IgY Against CSBV (CSBV) is the most serious threat to bee health and has caused widespread concern among beekeepers and researchers. CSBV primarily affects the brood of honeybees and results in larval death (Ghosh et al, 1999), as well as reducing the lifespan of adult bees (Bailey, 1969, 1976). Larvae that are between 1 and 3 days old are most susceptible to CSBV infection. CSBV infection occurs mainly in spring, when brood rearing begins. CSBV is widespread in China and Southeast Asia

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call